| Year |
Citation |
Score |
| 2023 |
Kloske CM, Barnum CJ, Batista AF, Bradshaw EM, Brickman AM, Bu G, Dennison J, Gearon MD, Goate AM, Haass C, Heneka MT, Hu WT, Huggins LKL, Jones NS, Koldamova R, et al. APOE and immunity: Research highlights. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36975090 DOI: 10.1002/alz.13020 |
0.688 |
|
| 2020 |
Joers V, Masilamoni G, Kempf D, Weiss AR, Rotterman TM, Murray B, Yalcin-Cakmakli G, Voll RJ, Goodman MM, Howell L, Bachevalier J, Green S, Naqib A, Shaikh M, Engen P, ... ... Barnum CJ, et al. Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series. Neurobiology of Disease. 105027. PMID 32712266 DOI: 10.1016/J.Nbd.2020.105027 |
0.722 |
|
| 2019 |
De Sousa Rodrigues ME, Houser MC, Walker DI, Jones DP, Chang J, Barnum CJ, Tansey MG. Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer's disease associated with obesity, metabolic syndrome, and type 2 diabetes. Alzheimer's Research & Therapy. 12: 1. PMID 31892368 DOI: 10.1186/S13195-019-0546-4 |
0.695 |
|
| 2019 |
Eidson LN, Rodrigues MED, Johnson MA, Barnum CJ, Duke BJ, Yang Y, Chang J, Kelly SD, Wildner M, Tesi RJ, Tansey MG. Chronic psychological stress during adolescence induces sex-dependent adulthood inflammation, increased adiposity, and abnormal behaviors that are ameliorated by selective inhibition of soluble Tumor Necrosis Factor with XPro1595. Brain, Behavior, and Immunity. PMID 31251975 DOI: 10.1016/J.Bbi.2019.06.027 |
0.557 |
|
| 2017 |
Eidson LN, Kannarkat GT, Barnum CJ, Chang J, Chung J, Caspell-Garcia C, Taylor P, Mollenhauer B, Schlossmacher MG, Ereshefsky L, Yen M, Kopil C, Frasier M, Marek K, Hertzberg VS, et al. Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease. Journal of Neuroinflammation. 14: 164. PMID 28821274 DOI: 10.1186/S12974-017-0935-1 |
0.725 |
|
| 2017 |
Karamita M, Barnum C, Möbius W, Tansey MG, Szymkowski DE, Lassmann H, Probert L. Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia. Jci Insight. 2. PMID 28422748 DOI: 10.1172/Jci.Insight.87455 |
0.524 |
|
| 2016 |
de Sousa Rodrigues ME, Bekhbat M, Houser MC, Chang J, Walker DI, Jones DP, Oller do Nascimento CM, Barnum CJ, Tansey MG. Chronic psychological stress and high-fat high-fructose diet disrupt metabolic and inflammatory gene networks in the brain, liver, and gut and promote behavioral deficits in mice. Brain, Behavior, and Immunity. PMID 27592562 DOI: 10.1016/J.Bbi.2016.08.021 |
0.688 |
|
| 2014 |
Burgado J, Harrell CS, Eacret D, Reddy R, Barnum CJ, Tansey MG, Miller AH, Wang H, Neigh GN. Two weeks of predatory stress induces anxiety-like behavior with co-morbid depressive-like behavior in adult male mice. Behavioural Brain Research. 275: 120-5. PMID 25200517 DOI: 10.1016/j.bbr.2014.08.060 |
0.5 |
|
| 2014 |
Barnum CJ, Chen X, Chung J, Chang J, Williams M, Grigoryan N, Tesi RJ, Tansey MG. Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats. Journal of Parkinson's Disease. 4: 349-60. PMID 25061061 DOI: 10.3233/JPD-140410 |
0.595 |
|
| 2013 |
Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M. Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity. Asn Neuro. 5: 113-39. PMID 23506036 DOI: 10.1042/An20120066 |
0.616 |
|
| 2012 |
Barnum CJ, Tansey MG. Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease? Current Neurology and Neuroscience Reports. 12: 350-8. PMID 22580742 DOI: 10.1007/S11910-012-0283-6 |
0.607 |
|
| 2012 |
Barnum CJ, Pace TW, Hu F, Neigh GN, Tansey MG. Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challenge. Journal of Neuroinflammation. 9: 9. PMID 22248083 DOI: 10.1186/1742-2094-9-9 |
0.559 |
|
| 2011 |
Barnum CJ, Tansey MG. The duality of TNF signaling outcomes in the brain: potential mechanisms? Experimental Neurology. 229: 198-200. PMID 21377463 DOI: 10.1016/J.Expneurol.2011.02.016 |
0.472 |
|
| 2011 |
Harms AS, Barnum CJ, Ruhn KA, Varghese S, Treviño I, Blesch A, Tansey MG. Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 46-52. PMID 20959812 DOI: 10.1038/Mt.2010.217 |
0.69 |
|
| 2010 |
Barnum CJ, Tansey MG. Modeling neuroinflammatory pathogenesis of Parkinson's disease. Progress in Brain Research. 184: 113-32. PMID 20887872 DOI: 10.1016/S0079-6123(10)84006-3 |
0.643 |
|
| Show low-probability matches. |